Synthese hochwirksamer Dekapeptide mit der Aminosäuresequenz des Val<sup>5</sup>‐Hypertensins I (<scp>L</scp>‐Asparagyl‐<scp>L</scp>‐arginyl‐<scp>L</scp>‐valyl‐<scp>L</scp>‐tyrsyl‐<scp>L</scp>‐valyl‐<scp>L</scp>‐histidyl‐<scp>L</scp>‐prolyl‐<scp>L</scp>‐phenylalanyl‐<scp>L</scp>‐histidyl‐<scp>L</scp>‐leucin und <scp>L</scp>‐Asparaginyl‐<scp>L</scp>‐arginyl‐<scp>L</scp>‐valyl‐<scp>L</scp>‐tyrosyl‐<scp>L</scp>‐valyl‐<scp>L</scp>‐histidyl‐<scp>L</scp>‐prolyl‐<scp>L</scp>‐phenylalanyl‐<scp>L</scp>‐histidyl‐<scp>L</scp>‐leucin)

R. Schwyzer, B. Iselin, H. Kappeler, B. Riniker, W. Rittel, H. Zuber

Helvetica Chimica Acta · 1958 · 60 citations · 21 references

Concepts

Abstract

Abstract The preliminarily published synthesis( 4 ) of decapeptides with the amino acid sequence of Val 5 ‐hypertensin I has been repeated several times. The products showed a high hypertensive activity, comparable with that of the corresponding octapeptides [Val 5 ‐hypertensin II and Val 5 ‐hypertensin II‐Asp‐β‐amide( 12 )]. The synthesis yielding the purest intermediates and products is described in this paper. The high chemical purity of the synthetic Val 5 ‐hypertensin I and Val 5 ‐hypertensin I‐Asp‐β‐amide was ascertained by countercurrent distribution, paper chromatography, elemental analysis, and determination of amino acids after hydrolysis. The free, crystalline peptides H · Val‐Tyr · OH ( L–L ), H · Val‐His · OH ( L–L ), H · Val‐Tyr‐Val · OH (L 3 ), H · Val‐Tyr‐Val‐His · OH (L 4 ) and H · Pro‐Phe · OH ( L–L ) were prepared from intermediates of the synthesis.

References

21